There are several advantages to conducting a clinical trial in Australia such as:

• Excellent telemedicine infrastructure to enable remote case support

• Some of the world’s best researchers and health professionals

• World-class research infrastructure and excellent quality research
• A very a stable political environment
• A robust intellectual property infrastructure
• Efficient ethics and regulatory framework
• Diverse participant recruitment pool

The Australian Government is invested in providing resources and incentives such as the Research & Development (R&D) Tax Incentive

The Incentive provides businesses investing in eligible R&D with generous tax offsets:

• a 45 per cent refundable R&D tax offset (equivalent to 45c per $1 of eligible R&D) for companies with aggregated annual turnover of less than A$20 million; and
• a 40 per cent non-refundable R&D tax offset (equivalent to 40c per $1 of eligible R&D) for all other eligible companies.

Other benefits under the new R&D Tax Incentive include:

• Clinical trials can be eligible R&D activities under the program and are considered for eligibility under the same rules as any other activity;
• The Incentive provides for increased access by international companies. In particular, there is no requirement to hold the intellectual property in Australia;
• Certainty and stability of the rate of support to companies as the rates are no longer linked to the company tax rate;
• Increased level of expenditure that can be claimed on R&D activities undertaken overseas in support of Australian R&D projects, under certain conditions.